Then, FCM analysis further confirmed that the proportion of CD45+ tumor-infiltrating leukocytes (TILs) in the SR group was 7.84 ± 1.68%, which was 3.4-fold higher than that of controls (2.32 ± 0.25%) (Supplementary Fig. 3a). The gene discussed is PTPRC; the disease is neoplasm.